Adiposity and health economics;Adipositas og sundhedsøkonomi: Oversigt og status

Ugeskrift for Laeger

Volumn 168, Issue 2, 2006, Pages 196-201

  Pedersen, Kjeld Møller ^a   Worre Jensen, Ann Louise ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEALTH ECONOMICS; OBESITY; PREVALENCE; REVIEW; COST BENEFIT ANALYSIS; ECONOMICS; GASTROPLASTY; HEALTH CARE COST; HUMAN; INTERVENTION STUDY; SOCIOECONOMICS; STOMACH BYPASS;

ANTIOBESITY AGENT;

ANTI-OBESITY AGENTS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; GASTRIC BYPASS; GASTROPLASTY; HEALTH CARE COSTS; HUMANS; INTERVENTION STUDIES; OBESITY; OVERWEIGHT; SOCIOECONOMIC FACTORS;

EID: 33644808097     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Philipson T, Cai C, Helmchen L. The economics of obesity. A report on the workshop held at USDA's Economic Research Service. E-FAN, 2004, no. (04004):45.
2. Drummond M, O'Brien B, Stoddart GL et al. Methods for the economic evaluation of health care programmes. Second edition. Oxford: Oxford University Press, 1997.
3. Kortt MA, Langley PC, Cox ER. A review of cost-of-illness studies on obesity. Clin Ther 1998;20:772-9.
4. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001;2:189-97.
5. NAO. Tackling Obesity in England. Report by the Comptroller and Auditor General. HC 220 Session 2000-2001. London: Comptroller and Auditor General, 2001.
6. Colditz GA. Economic costs of obesity. Am J Clin Nutr 1992;55:503S-7S.
7. Segal L, Carter R, Zimmet P. The cost of obesity: the Australian perspective. Pharmacoeconomics 1994;5:45-52.
8. Seidell JC. The impact of obesity on health status: some implications for health care costs. Int J Obes Relat Metab Disord 1995;19(suppl 6):S13-S16.
9. Swinburn B, Ashton T, Gillespie J et al. Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord 1997;21:891-6.
10. Detournay B, Fagnani F, Phillippo M et al. Obesity morbidity and health care costs in France: an analysis of the 1991-1992 Medical Care Household Survey. Int J Obes Relat Metab Disord 2000;24:151-5.
11. Levy E, Levy P, Le Pen C et al. The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord 1995;19:788-92.
12. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97-106.
13. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999;31:S663-S667.
14. Allison DB, Zannolli R, Narayan KM. The direct health care costs of obesity in the United States. Am J Pub Health 1999;89:1194-9.
15. Birmingham CL, Muller JL, Palepu A et al. The cost of obesity in Canada. CMAJ 1999;160:483-8.
16. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003;Suppl Web Exclusives:W3-26.
17. Wolf AM, Colditz GA. The cost of obesity: the US perspective. Pharmacoeconomics 1994;5:34-7.
18. Narbro K, Jonsson E, Larsson B et al. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes Relat Metab Disord 1996;20:895-903.
19. Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol 2004;29:90-115.
20. Roux L, Donaldson C. Economics and obesity: costing the problem or evaluating solutions? Obes Res 2004;12:173-9.
21. Raebel MA, Malone DC, Conner DA et al. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med 2004;164:2135-40.
22. Thompson D, Brown JB, Nichols GA et al. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res 2001;9:210-8.
23. Narbro K, Agren G, Jonsson E et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002;162:2061-9.
24. Agren G, Narbro K, Jonsson E et al. Cost of in-patient care over 7 years among surgically and conventionally treated obese patients. Obes Res 2002;10:1276-83.
25. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood.) 2002;21:245-53.
26. Foxcroft DR, Milne R. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model. Obes Rev 2000;1:121-6.
27. O'Meara S, Riemsma R, Shirran L et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. Health Technol Assess 2001;5:1-81.
28. Lamotte M, Annemans L, Lefever A et al. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Diabetes Care 2002;25:303-8.
29. O'Meara S, Riemsma R, Shirran L et al. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. Health Technol Assess 2002;6:1-97.
30. Clarke PM, Gray AM, Briggs A et al. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 2005;48:868-77.
31. Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002;6:1-153.
32. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? J Am Coll Surg 2005;200:270-8.
33. Salkeld G, Phongsavan P, Oldenburg B et al. The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health Policy 1997;41:105-19.
34. Baum CL, Ford WF. The wage effects of obesity: a longitudinal study. Health Econ 2004;13:885-99.
35. Bhattacharya J, Bundorf MK. The incidence of the health care costs of obesity. New York: National Bureau of Economic Research, 2005: Working Paper 11303 2005.
36. French SA. Pricing effects on food choices. J Nutr 2003;133:841S-843S.
37. Drewnowski A. Fat and sugar: an economic analysis. J Nutr 2003;133:838S-840S.
38. Cutler DM, Glaeser EL, Shapiro JM. Why have american become more obese. J Econ Perspect 2003;17:95-118.
39. Lakdawalla D, Philipson T. The growth of obesity and technological change: a theoretical and empirical examination. New York: National Bureau of Economic Research, 2002:8946 2002.
40. Fogel RW. Economic growth, population theory, and physiology: the bearing of long-term processes on the making of economic policy. Am Econ Rev 2001;84:369-95.